Title: Water-soluble pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as human A₃ adenosine receptor antagonists.
Journal: Journal of medicinal chemistry20120614
Title: Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists.
Journal: Bioorganic & medicinal chemistry20120115
Title: New 2-heterocyclyl-imidazo[2,1-i]purin-5-one derivatives as potent and selective human A3 adenosine receptor antagonists.
Journal: Journal of medicinal chemistry20110728
Title: QSAR of adenosine receptor antagonists: Exploring physicochemical requirements for binding of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives with human adenosine A(3) receptor subtype.
Journal: Bioorganic & medicinal chemistry letters20110115
Title: Combining selectivity and affinity predictions using an integrated Support Vector Machine (SVM) approach: An alternative tool to discriminate between the human adenosine A(2A) and A(3) receptor pyrazolo-triazolo-pyrimidine antagonists binding sites.
Journal: Bioorganic & medicinal chemistry20090715
Title: Docking studies of agonists and antagonists suggest an activation pathway of the A3 adenosine receptor.
Journal: Journal of molecular graphics & modelling20061201
Title: Pharmacophore based receptor modeling: the case of adenosine A3 receptor antagonists. An approach to the optimization of protein models.
Journal: Journal of medicinal chemistry20060713
Title: Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells.
Journal: Biochemical pharmacology20060628
Title: Adenosine receptors as therapeutic targets.
Journal: Nature reviews. Drug discovery20060301
Title: Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors.
Journal: Biochemical pharmacology20051125
Title: Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A3 adenosine receptor antagonists: pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as a key study.
Journal: Journal of medicinal chemistry20050113
Title: 1,2,4-Triazolo[5,1-i]purine derivatives as highly potent and selective human adenosine A(3) receptor ligands.
Journal: Journal of medicinal chemistry20020815
Title: Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A(3) adenosine receptor antagonists.
Journal: Journal of medicinal chemistry20020214
Title: A(3) adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study.
Journal: Molecular pharmacology20020201
Title: Binding thermodynamics at the human A(3) adenosine receptor.
Journal: Biochemical pharmacology20020115
Title: Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line.
Journal: British journal of pharmacology20011101
Title: Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells.
Journal: British journal of pharmacology20010901
Title: Fluorosulfonyl- and bis-(beta-chloroethyl)amino-phenylamino functionalized pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: irreversible antagonists at the human A3 adenosine receptor and molecular modeling studies.
Journal: Journal of medicinal chemistry20010816
Title: [(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors.
Journal: Molecular pharmacology20000501
Title: Synthesis and preliminary biological evaluation of [3H]-MRE 3008-F20: the first high affinity radioligand antagonist for the human A3 adenosine receptors.
Journal: Bioorganic & medicinal chemistry letters20000207
Title: Gessi S, et al. Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation. Mol Pharmacol. 2004 Mar;65(3):711-9.
